Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction
Z Lotfollahi, APQ Mello, FAH Fonseca, LO Machado… - PloS one, 2022 - journals.plos.org
Background Despite lipid-lowering and antiplatelet therapy, the pattern of residual
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …
lipoproteins seems relevant to long-term cardiovascular outcomes. This study aims to …
Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction
LCS Pinto, APQ Mello, MCO Izar… - Lipids in Health and …, 2021 - Springer
Background Large observational studies have shown that small, dense LDL subfractions are
related to atherosclerotic cardiovascular disease. This study assessed the effects of two …
related to atherosclerotic cardiovascular disease. This study assessed the effects of two …
Cholesterol subfraction analysis in patients with acute coronary syndrome
M Kidawa, A Gluba-Brzózka, M Zielinska… - Current Vascular …, 2019 - ingentaconnect.com
Background: There is a close relationship between lipid metabolism disorders and
atherosclerosis. Guidelines focus on lowering Low-Density Lipoprotein Cholesterol (LDL-C) …
atherosclerosis. Guidelines focus on lowering Low-Density Lipoprotein Cholesterol (LDL-C) …
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial
AG Olsson, GG Schwartz, M Szarek… - European heart …, 2005 - academic.oup.com
Aims Patients with acute coronary syndrome (ACS) in the Myocardial Ischaemia Reduction
with Aggressive Cholesterol Lowering (MIRACL) study had diminished cardiovascular …
with Aggressive Cholesterol Lowering (MIRACL) study had diminished cardiovascular …
Evaluation of two highly effective lipid-lowering therapies in subjects with acute myocardial infarction
A Klassen, AT Faccio, CRC Picossi, PBMC Derogis… - Scientific Reports, 2021 - nature.com
For cardiovascular disease prevention, statins alone or combined with ezetimibe have been
recommended to achieve low-density lipoprotein cholesterol targets, but their effects on …
recommended to achieve low-density lipoprotein cholesterol targets, but their effects on …
Prevalence and predictors of out-of-target LDL cholesterol 1 to 3 Years after myocardial infarction. A subanalysis from the EYESHOT post-MI registry
A Silverio, RM Benvenga, F Piscione… - Journal of …, 2021 - journals.sagepub.com
Background: There is an incomplete understanding of the prevalence and predictors of
attainment of low-density lipoprotein cholesterol (LDL-C) goal after myocardial infarction …
attainment of low-density lipoprotein cholesterol (LDL-C) goal after myocardial infarction …
High-density lipoprotein and low-density lipoprotein therapeutic approaches in acute coronary syndromes
E Androulakis, E Zacharia… - Current Cardiology …, 2017 - ingentaconnect.com
Background: Low-density lipoprotein cholesterol (LDL), and especially its oxidized form,
renders the atherosclerotic plaque vulnerable to rupture in acute coronary syndromes …
renders the atherosclerotic plaque vulnerable to rupture in acute coronary syndromes …
Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age)
G Goliasch, S Oravec, H Blessberger… - European journal of …, 2012 - Wiley Online Library
Eur J Clin Invest 2012; 42 (6): 631–636 Abstract Background Low‐density lipoprotein (LDL)
cholesterol lowering has been established as one of the principal targets in preventive …
cholesterol lowering has been established as one of the principal targets in preventive …
Lipid profile associated with coronary plaque regression in patients with acute coronary syndrome: subanalysis of PRECISE-IVUS trial
K Tsujita, K Yamanaga, N Komura, K Sakamoto… - Atherosclerosis, 2016 - Elsevier
Background and aims Although dual low-density lipoprotein cholesterol (LDL-C)-lowering
therapy (DLLT) with statin-ezetimibe combination showed clinical benefit in patients with …
therapy (DLLT) with statin-ezetimibe combination showed clinical benefit in patients with …
Effect of metformin treatment on lipoprotein subfractions in non-diabetic patients with acute myocardial infarction: a glycometabolic intervention as adjunct to primary …
RN Eppinga, MHT Hartman, DJ van Veldhuisen… - PLoS …, 2016 - journals.plos.org
Objective Metformin affects low density lipoprotein (LDL) and high density (HDL)
subfractions in the context of impaired glucose tolerance, but its effects in the setting of acute …
subfractions in the context of impaired glucose tolerance, but its effects in the setting of acute …